The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrestAlexandre Pichard, Jean‐Pierre Pouget, Riad Ladjohounlou et al.|Leukemia|2019Cited by 25
Realistic multi-cellular dosimetry for<sup>177</sup>Lu-labelled antibodies: model and applicationS Marcatili, Manuel Bardiès, Alexandre Pichard et al.|Physics in Medicine and Biology|2016Cited by 21